Agile Therapeutics to Present at Upcoming Investor Conferences
September 06 2019 - 7:30AM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, announced today that its Chairman and Chief Executive
Officer, Al Altomari, will present at two upcoming investor
conferences in New York City, where he will provide an overview of
the company’s business and upcoming milestones.
Details of Agile’s presentations are as follows:
Event: 2019 Janney Montgomery Scott Healthcare
Conference
Date: Monday, September 9, 2019
Time: 9:05 a.m. EDT
Location: The Union League Club, New York, NY
Event: 21st Annual Global Rodman and Renshaw Investment
Conference, sponsored by H. C. Wainwright
Date: Tuesday, September 10, 2019
Time: 2:10 p.m. EDT
Location: Lotte New York Palace, New York, NY
To access the live and archived webcasts of the presentations,
visit the Investor Relations section of the Agile
Therapeutics website at www.agiletherapeutics.com.
The webcast will be archived on the Agile Therapeutics website
for 60 days following the event.
About Agile Therapeutics, Inc. Agile
Therapeutics is a forward-thinking women's healthcare company
dedicated to fulfilling the unmet health needs of today’s
women. Our product candidates are designed to provide women
with contraceptive options that offer freedom from taking a daily
pill, without committing to a longer-acting method. Our lead
product candidate, Twirla®, (ethinyl estradiol and levonorgestrel
transdermal system), also known as AG200-15, is an investigational
low-dose, non-daily prescription contraceptive. Twirla is based on
our proprietary transdermal patch technology, called Skinfusion®,
which is designed to allow drug delivery through the skin. For more
information, please visit the company website
at www.agiletherapeutics.com. The Company may
occasionally disseminate material, nonpublic information on the
Company’s website.
Contact: Investor Relations -- 609-683-1880
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Sep 2023 to Sep 2024